Human L-interleukin 8 (Hu IL-8) ELISA quantifies Hu IL-8 in human serum, plasma, buffered solution or cell culture medium. The dosage will recognize only natural and recombinant l'IL-8 Hu. Method principle...
Human L的interleukin 8 (Hu IL-8) ELISA quantifies Hu IL-8 in human serum, plasma, buffered solution or cell culture medium. The dosage will recognize only natural and recombinant Hu IL-8. The principle of the human lIL-8 solid-phase sandwich (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-assembled in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
IL-8 (Interleukine-8) is an amino acid 72 pro-inflammatory CXC chemokine called CXCL8, secreted by endothelial cells and monocytes, which acts as an important chemotactic for neutrophils as well as T cells and basophiles. Il-8, isolated for the first time from the cells of the osteosarcoma, contains the ELR pattern (the sequence of amino acids end to end N-terminal Glu-Leu-Arg) and signals via the CXCR1 and CXCR2 receptors. Cancer studies have shown a role for IL-8 in angiogenesis and tumour growth. The previous nomenclature for the IL-8 includes neutrophil 1 (NAP-1), granulocyte 1 (GCP-1) chemotactic protein, neutrophil monocyte-derived activator peptide (MONAP) and protein 3-10 C. Order information
Shipping conditions: Wet ice
Sensitivity
Sensitivity of the dosage: 0.7 pg/ml.
Measurement range
Dose range: 7-750 pg/ml.
Duration of dosing
Total duration of dosing: 2 h 30 min.
Reproducibility
Intra-dose variation coefficient 4.2%, inter-dose 3.7%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 10008992 |
| Specifications |
| Accession number | P10145 |
| Dose range | 7-750 pg/ml |
| Sensitivity of the dosage | 0.7 pg/ml |
| Conjugate | HRP |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Surnatant |
| Target species | Human |
| For use with (application) | Colorimetric |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 3576 |
| Gene symbol(s) | GCP-1,GCP1,IL8,LECT,LUCT,LYNAP,MDNCF,MONAP,NAF,NAP-1,NAP1 |
| Coefficient of inter-dose variation | 3.7% |
| Coefficient of intra-dose variation | 4.2% |
| Contents of kits | 96-well pre-coated plate, Calibration, Standard dilution stamp, Incubation stamp, HRP conjugate detection antibody, Wash pad, Chromogen, Stop solution, isotypic |
| Marker or dye | HRP |
| Accuracy | 0.7 pg/ml |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 100 μl; serum, 100 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 2 h 30 min |
Origin and customs
| Manufacturer ref. | KAC1301 |
|---|
| Country of origin | United Kingdom |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.